Characterization of the adipose tissue atrophy induced by peroxisome proliferators in mice

Lipids

Volumn 37, Issue 2, 2002, Pages 139-146

  Xie, Yi ^a   Yang, Qian ^a   Nelson, B Dean ^a   DePierre, Joseph W ^a  

^a STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; SENSITIVITY ANALYSIS; TISSUE; TUMORS;

NECROSIS FACTORS;

LIPIDS;

ACETYLSALICYLIC ACID; DNA; FAT; FATTY ACID; HORMONE SENSITIVE LIPASE; INSULIN; LIPOPROTEIN LIPASE; NAFENOPIN; PERFLUOROOCTANOIC ACID; PEROXISOME PROLIFERATOR; PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER; PIRINIXIC ACID; TRIACYLGLYCEROL LIPASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATROPHY; BODY FAT; BODY WEIGHT; CELL LOSS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA CONTENT; DOSE TIME EFFECT RELATION; DRUG MECHANISM; ENZYME ACTIVITY; EPIDIDYMIS; FATTY ACID METABOLISM; FATTY ACID OXIDATION; FATTY ACID TRANSPORT; INSULIN SENSITIVITY; LIPID METABOLISM; LIPOLYSIS; LIVER METABOLISM; LIVER MITOCHONDRION; LIVER WEIGHT; MALE; MOUSE; NONHUMAN; PEROXISOME; RETROPERITONEUM; TREATMENT OUTCOME;

ANIMALIA;

EID: 0036198519     PISSN: 00244201     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11745-002-0873-7     Document Type: Article

References (43)

1. Mechanism of action of the nongenotoxic peroxisome proliferators: Role of the peroxisome proliferator-activator receptor α
2. Do peroxisome proliferating compounds pose a hepatocarcinogenic hazard to humans?
3. An Update on the mechanisms of action of the Peroxisome Proliferator-Activated Receptors (PPAR) and their roles in inflammation and cancer
4. Apolipoproteins C-II and C-III metabolism in hypertriglyceridemic patients. Effect of a drastic triglyceride reduction by combined diet restriction and fenofibrate administration
5. Fibrates down-regulate apolipoprotein C-III expression independent of induction of peroxisomal acyl coenzyme A oxidase. A potential mechanism for the hypolipidemic action of fibrates
6. Transcriptional control of triglyceride metabolism: Fibrates and fatty acids change the expression of the LPL and Apo C-III genes by activating the nuclear receptor PPAR
7. Positive regulation of the peroxisomal β-oxidation pathway by fatty acids through activation of peroxisome proliferator-activated receptors (PPAR)
8. The peroxisome proliferator activated receptors (PPAR) and their effects on lipid metabolism and adipocyte differentiation
9. Peroxisome proliferator-activated receptor α activators improve insulin sensitivity and reduce adiposity
10. Fenofibrate prevents and reduces body weight gain and adiposity in diet-induced obese rats
11. Conjugated linoleic acid supplementation reduces adipose tissue by apoptosis and develops lipodystrophy in mice
12. Effects of peroxisome proliferators on the thymus and spleen of mice
13. Effects of dietary treatment with clofibrate, nafenopin or WY-14,643 on mitochondria and DNA in mouse liver
14. Induction of xenobiotic-metabolizing enzymes and peroxisome proliferation in rat liver caused by dietary exposure to Di(2-ethylhexyl) phosphate
15. Perfluorooctanoic acid has persistent effects on peroxisome proliferation and related parameters in mouse liver
16. Effects of acetylsalicylic acid on parameters related to peroxisome proliferation in mouse liver
17. Lipid interference with fluorometric assay of DNA in adipose tissue under varous conditions
18. Characterization of a fluorometric method for lipoprotein lipase
19. A Rapid spectrophotometric assay for carnitine palmitoyltransferase
20. Determination of peroxisomal fatty Acyl-CoA oxidase activity using a Lauroyl-CoA-based fluorometric assay
21. Studies with etofibrate in the rat. Part I: Effects on glycerol, free fatty acid and triacylglycerol metabolism
22. Adipose conversion of cultured rat primary preadipocytes by hypolipidemic drugs
23. A rapid enzymatic assay for glycerol
24. Rapid fluorometric quantification of monocyte attachment in tissue culture wells
25. Protein measurement with the folin phenol reagent
26. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
27. Effects of peroxisome proliferators on rat liver phospholipids: Sphingomyelin degradation may be involved in hepatotoxic mechanism of perfluorodecanoic acid
28. Receptor and nonreceptor-mediated organ-specific toxicity of Di(2-ethylhexyl)phthalate (DEHP) in peroxisome proliferator-activated receptor a-null mice
29. Involvement of the peroxisome proliferator-activated receptor alpha in the immunomodulation caused by peroxisome proliferators in mice
30. Further evidence for the involvement of inhibition of cell proliferation and development in thymic and splenic atrophy induced by the peroxisome proliferator perfluorooctanoic acid in mice
31. Tumor necrosis factor α prevents the differentiation of human adipocyte precursor cells and causes delipidation of newly developed fat cells
32. A Simple method to determine fat cell size and number in four mammalian species
33. PPARα and PPARγ activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene
34. The PPARs: From orphan receptors to drug discovery
35. Insulin-and mitogen-activated protein kinase-mediated phosphorylation and activation of peroxisome proliferator-activated receptor γ
36. Hormonal regulation of hormone-sensitive lipase in intact adipocytes: Identification of phosphorylated sites and effects on the phosphorylation by lipolytic hormones and insulin
37. Cachectin, tumor necrosis factor α: A macrophage hormone governing cellular metabolism and inflammatory response
38. Tumor necrosis factor-α is a direct hepatocyte mitogen in the rat
39. Adipose expression of tumor necrosis factor-α: Direct role in obesity-linked insulin resistance
40. The role of TNF-α in human adipose tissue: Prevention of weight gain at the expense of insulin resistance?
41. Effect of peroxisome proliferator-activated receptor α activators on tumor necrosis factor expression in mice during endotoxemia
42. Down regulation of peroxisome proliferator-activated receptory expression by inflammatory cytokines and its reversal by thiazolidinediones
43. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α-and obesity-induced insulin resistance